New Drug Approved for Wet Macular Degeneration

Novartis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved it’s new drug, Beovu®, for the treatment of wet age-related macular degeneration (AMD). Beovu® (brolucizumab) recently completed two late-stage clinical trials, which tested the safety and efficacy of the intravitreal injection. Wet AMD is an eye condition which can lead to a […]

Digital therapy for children with ‘lazy eye’

A new digital therapy platform has been released to help patients with amblyopia, otherwise known as “lazy eye”. The subscription-based technology is available from the startup, AmblyoPlay. Progress can be monitored through a progression tracker and shared with eye care providers. Amblyopia is the most common visual impairment in children, with up to 3% of […]

Which Sunglasses Best Protect Your Vision?

While sunglasses are often deemed to be no more than a fashion accessory, the impact that they have on your vision is critically important. The choice of your sunglasses is every bit as important as your choice of sun block for your skin. The National Eye Institute reports that UV radiation can damage proteins in […]

Why does VisiVite use FloraGLO Lutein in its AREDS 2 Formulas?

FloraGLO is the world’s most stable and bioavailable form of lutein, and is the premium brand that is used in all of VisiVite’s AREDS 2 Formulas for the support of Age-Related Macular Degeneration. For more information about VisiVite’s Professional Formulas for Ocular Nutrition, visit https://www.visivite.com/premier-macular-health-eye-vitamins.html.

Don’t Blink – Save $50 off VisiVite!

VisiVite’s End-Of Summer Sale! Put $150 of any combination of VisiVite eye vitamins in your VisiVite.com shopping cart, then use the online coupon code 50DOLLARS to immediately discount your purchase by $50.00. (Don’t forget to click the UPDATE CART TOTAL button!) This coupon expires FRIDAY, SEPTEMBER 20, 2019 – the last day of summer. Due to the […]

FDA approves trifocal cataract surgery lens

The Food and Drug Administration (FDA) has recently approved the first trifocal intraocular lens from Alcon, for use in patients undergoing cataract surgery in the United States. Clinical studies demonstrated that the lens offers patients outstanding near, intermediate and distance vision while also reducing the need for glasses post-op. With more than 4 million cataract […]

air pollution for exhaust pipes

Air pollution a factor in macular degeneration

Study results recently published in the Journal of Investigative Medicine point to a link between air pollutants and an increased risk of developing age-related macular degeneration. This is the first study to show a notable association between macular degeneration and high levels of atmospheric pollution. The study was conducted in Taiwan and involved tracking levels […]

Medication for Dry Macular Degeneration Coming Soon?

While Wet Macular Degeneration has enjoyed the fruits of great research and effective medications, the more common Dry Macular Degeneration has no similar medications for treatment. That might be changing soon. The company, Allegro Ophthalmics, LLC, has developed the molecule, Risuteganib, which the company states is effective against the oxidative stress in the retina that […]

Why are more children becoming nearsighted?

The National Eye Institute is sponsoring a study to determine the effect of red and blue light on children’s vision. The University of Houston College of Optometry has a lab set up and children aged 7 to 14 who are accompanied by a guardian sleep over and are exposed to red and blue lights at […]

Does Bad Sleep Cause Glaucoma?

Glaucoma is a potentially blinding eye disease with damage to the optic nerve that is sometimes associated with high pressure inside the eye. Because you cannot feel glaucoma or notice the vision loss until a very late stage, glaucoma is a sneaky and sometimes devastating disease. That’s why it’s important to be regularly checked by […]